BioRestorative Therapies, Inc. (BRTX): Bathi resik saben saham (EPS TTM)

BRTX (BioRestorative) - tandha merek perusahaan

BioRestorative Therapies (BRTX) develops cell-based therapies for intervertebral disc regeneration using patients' own tissues. The rolling trailing twelve-month earnings per share reflect the impact of zero sales and high capital expenditure. The -22.32 mark serves as a current indicator confirming that the securities' value depends on the future success of the ThermoStem platform and the scientific expertise of the management team.

BRTX (BioRestorative Therapies) riwayat Bathi resik saben saham sajrone patang kuartal pungkasan saka 04.07.2022 nganti 16.11.2026

Rincian analitis perusahaan BioRestorative (BRTX)

- kuotasi saiki lan rata-rata prakiraan nilai:
Analisis dhasar perusahaan:BRTX - BioRestorative Therapies
Produk seri BioRestorative Therapies Inc

Comparing assets via earnings per share allows an investor to objectively assess capital generation efficiency. This metric is calculated as the ratio of net income to the total number of outstanding shares over a rolling year. For BioRestorative Therapies (BRTX), negative values reflect R&D expenditures and a reliance on external financing. Registration risks for discogenic pain therapy directly impact the dynamics of this indicator. By analyzing the change in EPS over 12 months, one can determine the business's development vector.